Generics

Press enter to search
Close search
Open Menu

Generics

News and information on generic drugs sold in retail pharmacies, as well as their suppliers.

Pharmacy shelves with various medications.

Hikma pauses generic Advair Diskus launch

Following the FDA's approval of Hikma’s ANDA for generic Advair Diskus in December 2020, Hikma has submitted an amendment to its application to the FDA which reflects enhanced packaging controls to meet new industry standards adopted since the initial submission of its ANDA application.

A pharmacist preparing a prescription in a bottle.

Sun Pharma intros 2 generics

Sun Pharma is launching docetaxel injection and relaunching its valacyclovir tablets.

Etonogestrel and ethinyl estradiol vaginal ring products had a market value of more than $837 million, according to IQVIA November 2020 data.

Vials containing injection.

The Food and Drug Administration has informed Biocon Biologics and Mylan, a subsidiary of Viatris, of a deferred action on the biologics license application for MYL-14020, a biosimilar to Roche's Avastin (bevacizumab).

Two modern office buildings.

With its acquisition of Kashiv Specialty, Amneal will gain a pipeline of 505(b)2 branded products primarily in neurology and endocrinology, as well as a pipeline of complex generics.

Alembic's Timolol Maleate Ophthalmic Gel Forming Solution provides treatment for elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

White tablets spilling out of a prescription bottle.

The Uloric brand and generic had a market value of approximately $108 million for the most recent 12 months ended October 2020, according to IQVIA.

White pills spilling out of a bottle.

The Food and Drug Administration approved Amneal’s abiraterone acetate tablets in a dosage strength of 500 mg.

Generic pill bottles.

Sun Pharmaceutical's methylphenidate hydrochloride ER tablets are available in four dosage strengths.

Oral liquid bottle.

Sulfamethoxazole and trimethoprim oral suspension has a market value of approximately $19 million.

A hand signing a document that another hand is holding.

The Everstone Group is investing up to $50 million in Series B funding to expand and accelerate Slayback's pipeline of complex generic and specialty pharmaceutical products.

A pharmacist preparing a prescription in a bottle.

Amitiza had a market value of approximately $427 million for the 12 months ended Sept. 30, 2020, according to IQVIA.

Generic pill bottles.

The Mahwah, N.J.-based company has received approval or tentative approval for generics of Otezla, Cialis and Horizant.

Various generic pills and capsules.

Biocon's tacrolimus capsules reduces the body’s ability to reject a transplanted organ.

Show More